دورية أكاديمية
أعرض في EDS

Incidence of Adverse Drug Reactions in High-Risk Pregnancy: A Prospective Cohort Study in Obstetric Intensive Care.

التفاصيل البيبلوغرافية
العنوان: Incidence of Adverse Drug Reactions in High-Risk Pregnancy: A Prospective Cohort Study in Obstetric Intensive Care.
المؤلفون: da Costa TX; Postgraduate Program in Pharmaceutical Sciences, Centro de Ciências da Saúde, Universidade Federal do Rio Grande do Norte, Natal, Brazil. tatycx1000@gmail.com.; Maternity School Januário Cicco, Centro de Ciências da Saúde, Universidade Federal do Rio Grande do Norte, Natal, Brazil. tatycx1000@gmail.com.; Faculdade de Farmácia, Centro de Ciências da Saúde, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil. tatycx1000@gmail.com., de Almeida Pimenta Cunha MD; Postgraduate Program in Pharmaceutical Sciences, Centro de Ciências da Saúde, Universidade Federal do Rio Grande do Norte, Natal, Brazil.; Maternity School Januário Cicco, Centro de Ciências da Saúde, Universidade Federal do Rio Grande do Norte, Natal, Brazil., do Vale Bezerra PK; Postgraduate Program in Pharmaceutical Sciences, Centro de Ciências da Saúde, Universidade Federal do Rio Grande do Norte, Natal, Brazil., Azeredo FJ; Department of Pharmacy, Faculdade de Farmácia, Universidade Federal da Bahia, Salvador, Brazil., Martins RR; Department of Pharmacy, Centro de Ciências da Saúde, Universidade Federal do Rio Grande do Norte, Natal, Brazil., Oliveira AG; Department of Pharmacy, Centro de Ciências da Saúde, Universidade Federal do Rio Grande do Norte, Natal, Brazil.
المصدر: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2020 Feb; Vol. 76 (2), pp. 291-298. Date of Electronic Publication: 2019 Nov 25.
نوع المنشور: Journal Article; Observational Study
اللغة: English
بيانات الدورية: Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Berlin, New York, Springer.
مواضيع طبية MeSH: Pregnancy, High-Risk*, Drug-Related Side Effects and Adverse Reactions/*epidemiology , Intensive Care Units/*statistics & numerical data, Adult ; Cohort Studies ; Female ; Hospitalization ; Humans ; Incidence ; Longitudinal Studies ; Magnesium Sulfate/administration & dosage ; Magnesium Sulfate/adverse effects ; Pregnancy ; Prospective Studies ; Risk Factors ; Young Adult
مستخلص: Purpose: To estimate the cumulative incidence of adverse drug reactions (ADRs) in women with high-risk pregnancy hospitalized in an obstetric intensive care unit, then to describe the medicines involved and to identify major risk factors.
Methods: From June 2016 to December 2017, patients admitted to the ICU with high-risk pregnancy were considered eligible in this observational, longitudinal, prospective study. Patients were investigated daily for the occurrence of ADRs through pharmaceutical anamnesis, active search in medical records and questioning of the health team. Suspected ADRs were classified according to Naranjo's algorithm. Written informed consent was obtained from all patients. Univariate and multivariate logistic regression were used to identify risk factors of ADR.
Results: The study population consisted of 607 high-risk pregnancies from 851 women admitted to the ICU, of whom 244 admitted for non-obstetric conditions, with an ICU stay less than 24 h or readmitted to the ICU were excluded. The mean age was 27.0 ± 7.5 years-old, mean gestational age was 33.8 ± 6.3 weeks. ADR were observed in 165 women (27.2%). No severe ADR was observed and 29.7% were of moderate severity. The most often implicated medicine was magnesium sulphate (25.2%) with 44.5% of patients administered that substance experiencing ADRs consisting of somnolence (68.6%), absent patellar reflex (21.6%) and hypotension (9.8%). Risk factors of ADR were blood pressure (adjusted odds-ratio (aOR) 1.02), haemoglobin level (aOR 1.21) and body temperature (aOR 0.71).
Conclusions: ADRs affect about one third of high-risk pregnancies, mainly due to magnesium sulphate administrations. High blood pressure, lower body temperature, and high haemoglobin concentration on admission were associated with an increased risk of ADR.
References: Adv Chronic Kidney Dis. 2013 May;20(3):229-39. (PMID: 23928387)
J Pediatr. 2016 Nov;178:68-74. (PMID: 27453378)
BMC Pregnancy Childbirth. 2013 Oct 21;13:195. (PMID: 24139447)
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. (PMID: 7249508)
Arch Gynecol Obstet. 2006 Apr;274(1):4-8. (PMID: 16432668)
BMJ Open. 2014 Feb 17;4(2):e004365. (PMID: 24534260)
J Obstet Gynaecol Res. 2007 Apr;33(2):138-43. (PMID: 17441885)
Am J Obstet Gynecol. 2001 Sep;185(3):593-9. (PMID: 11568783)
Lancet. 2000 Nov 18;356(9243):1735-6. (PMID: 11095263)
Eur J Hosp Pharm. 2016 Jul;23(4):197-202. (PMID: 31156848)
Int J Obstet Anesth. 2019 Feb;37:96-105. (PMID: 30482716)
Am J Obstet Gynecol. 2004 Jun;190(6):1520-6. (PMID: 15284724)
Dev Psychol. 2002 Jan;38(1):93-103. (PMID: 11806705)
Curr Opin Anaesthesiol. 2015 Jun;28(3):290-9. (PMID: 25915201)
BMC Pregnancy Childbirth. 2013 Feb 05;13:34. (PMID: 23383864)
Acta Obstet Gynecol Scand. 2001 Nov;80(11):998-1002. (PMID: 11703195)
BJOG. 2007 Mar;114(3):300-9. (PMID: 17166220)
Arq Bras Cardiol. 2009 Dec;93(6 Suppl 1):e110-78. (PMID: 20694373)
Am J Obstet Gynecol. 2011 Jul;205(1):51.e1-8. (PMID: 21514558)
Lancet. 2016 Mar 5;387(10022):999-1011. (PMID: 26342729)
Pharmacoepidemiol Drug Saf. 2011 Sep;20(9):895-902. (PMID: 21774029)
Saudi Pharm J. 2017 Nov;25(7):1073-1077. (PMID: 29158717)
Anaesth Crit Care Pain Med. 2016 Oct;35 Suppl 1:S51-S57. (PMID: 27386763)
Intensive Care Med. 2010 Feb;36(2):256-63. (PMID: 19902177)
BJOG. 2016 Feb;123(3):356-66. (PMID: 26599617)
J Matern Fetal Neonatal Med. 2018 Jan;31(2):178-183. (PMID: 28056569)
Semin Perinatol. 2013 Aug;37(4):207-24. (PMID: 23916020)
Aust N Z J Obstet Gynaecol. 2011 Jun;51(3):233-8. (PMID: 21631442)
Crit Care Med. 1988 May;16(5):470-7. (PMID: 3359785)
Therapie. 2006 Jul-Aug;61(4):313-23. (PMID: 27393310)
JAMA. 1999 Jul 21;282(3):267-70. (PMID: 10422996)
Med Princ Pract. 2008;17(3):227-32. (PMID: 18408392)
J Clin Pharmacol. 2017 Nov;57(11):1419-1424. (PMID: 28589614)
F1000Res. 2019 Jun 20;8:null. (PMID: 31249673)
Am J Obstet Gynecol. 1987 Feb;156(2):435-6. (PMID: 3826181)
Am J Perinatol. 2014 Sep;31(8):711-6. (PMID: 24338122)
Nat Rev Nephrol. 2014 Sep;10(9):531-40. (PMID: 25003612)
Am J Obstet Gynecol. 2016 Sep;215(3):382.e1-6. (PMID: 27018467)
فهرسة مساهمة: Keywords: Adverse drug reactions; High-risk pregnancy; Intensive care; Magnesium sulphate
المشرفين على المادة: 7487-88-9 (Magnesium Sulfate)
تواريخ الأحداث: Date Created: 20191127 Date Completed: 20200930 Latest Revision: 20200930
رمز التحديث: 20240628
DOI: 10.1007/s00228-019-02789-9
PMID: 31768575
قاعدة البيانات: MEDLINE
الوصف
تدمد:1432-1041
DOI:10.1007/s00228-019-02789-9